Physician profile
Samantia N Wright
NPI 1457897076
$1,185.31
in general payments reported to CMS, 2019-2025
9 companies · $861 in 2025
The $861 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $28.69 · 2023: $15.63 · 2024: $155 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.17 |
| Education | $109.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $364.75 | 2021-2025 | Airsupra, Breztri |
| Teva Pharmaceuticals USA, INC. | $241.07 | 2025 | Austedo Xr |
| Lundbeck LLC | $152.28 | 2022-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $142.84 | 2024-2025 | Rexulti |
| Abbvie INC. | $141.27 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.11 | 2025 | Trintellix |
| Neurocrine Biosciences, INC. | $49.90 | 2022-2025 | |
| Novo Nordisk INC | $15.63 | 2023 | Rybelsus, Ozempic |
| Eisai INC. | $15.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantia Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.